27 May 2025 : Original article
Impact of Preoperative Treatment on Donor Hepatic Steatosis in Living Donor Liver Transplantation
Ahmet Atasever
ABCEF 1, Sinan Efe Yazıcı ABEF 1*, Tolga Şahin ABCF 1, Yıldıray Yuzer A 2
DOI: 10.12659/AOT.947772
Ann Transplant 2025; 30:e947772
Table 1 Characteristics of study groups (n).
| Patients receiving fatty liver treatment (n: 14) | Patients not receiving fatty liver treatment (n: 20) | P value | |
|---|---|---|---|
| Age(year) (mean±SD) | 37.5±7.2 years | 36.9±8.2 years | >0.05 |
| Female (n) | 1 | 5 | >0.05 |
| Male (n) | 13 | 15 | >0.05 |
| Higher BMI (>30) (n) | 8 | 2 | |
| Homa-IR elevation (n) | 6 | 0 | |
| HbA1c elevation (n) | 4 | 2 | >0.05 |
| Hyperglycemia | 6 | 0 |